▶ 調査レポート

のどあめの世界市場レポート2020

• 英文タイトル:Global Nodoame Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。のどあめの世界市場レポート2020 / Global Nodoame Sales Market Report 2020 / QY20ST-10273資料のイメージです。• レポートコード:QY20ST-10273
• 出版社/出版日:QYResearch / 2020年9月15日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、141ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:食品・飲料
• 販売価格(消費税別)
  Single User¥580,000 (USD4,000)▷ お問い合わせ
  Multi User¥870,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,160,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界ののどあめ市場について種類別(薬用、食品)、用途別(Supermarket、 Drugstore)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・のどあめ市場の概要
・世界の主要地域別のどあめ市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界ののどあめ市場規模2015-2026:種類別(薬用、食品)
・世界ののどあめ市場規模2015-2026:用途別(Supermarket、 Drugstore)
・のどあめの北米市場規模2015-2020
・のどあめのヨーロッパ市場規模2015-2020
・のどあめの中国市場規模2015-2020
・のどあめの日本市場規模2015-2020
・のどあめの東南アジア市場規模2015-2020
・のどあめのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・のどあめの製造コスト分析
・販売チャネル、流通業者、顧客
・のどあめの市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Nodoame Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Nodoame market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
A nodoame is a small tablet intended to be dissolved slowly in the mouth to temporarily soothe irritated tissues of the throat (usually due to a sore throa).
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nodoame market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Nodoame industry.
Based on our recent survey, we have several different scenarios about the Nodoame YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Nodoame will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Nodoame market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Nodoame market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Nodoame market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Nodoame market. The report also includes nautical information, where it shows Nodoame market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Nodoame market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Nodoame market.
Geographical Analysis:
Based on region, the global Nodoame market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Nodoame market are
Comvita
Vocalzone
Good Health
Kanro
UHA Mikakuto Co.,Ltd
RYUKAKUSAN Co.,Ltd.
Zirkulin
Ricola
Fisherman’s Friend
Golden Throat Holdings Group Company Limited
Nin Jiom
Wong Lo Kat
Poon Goor Soe
Guilin Sanjin Pharmaceutical Company Limited
Segment by Type
Medicinal
Food
Segment by Application
Supermarket
Drugstore
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Nodoame market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Nodoame market.
• The market share of the global Nodoame market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Nodoame market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Nodoame market.

レポート目次

1 Nodoame Market Overview
1.1 Nodoame Product Scope
1.2 Nodoame Segment by Type
1.2.1 Global Nodoame Sales by Type (2020-2026)
1.2.2 Medicinal
1.2.3 Food
1.3 Nodoame Segment by Application
1.3.1 Global Nodoame Sales Comparison by Application (2020-2026)
1.3.2 Supermarket
1.3.3 Drugstore
1.4 Nodoame Market Estimates and Forecasts (2015-2026)
1.4.1 Global Nodoame Sales Growth Rate (2015-2026)
1.4.2 Global Nodoame Revenue and Growth Rate (2015-2026)
1.4.3 Global Nodoame Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Nodoame Industry Impact
1.5.1 How the Covid-19 is Affecting the Nodoame Industry
1.5.1.1 Nodoame Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Nodoame Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Nodoame Players to Combat Covid-19 Impact

2 Nodoame Estimate and Forecast by Region
2.1 Global Nodoame Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Nodoame Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Nodoame Sales Market Share by Region (2015-2020)
2.2.2 Global Nodoame Revenue Market Share by Region (2015-2020)
2.3 Global Nodoame Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Nodoame Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Nodoame Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Nodoame Estimates and Projections (2015-2026)
2.4.2 Europe Nodoame Estimates and Projections (2015-2026)
2.4.3 China Nodoame Estimates and Projections (2015-2026)
2.4.4 Japan Nodoame Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Nodoame Estimates and Projections (2015-2026)
2.4.6 India Nodoame Estimates and Projections (2015-2026)
3 Global Nodoame Competition Landscape by Players
3.1 Global Top Nodoame Players by Sales (2015-2020)
3.2 Global Top Nodoame Players by Revenue (2015-2020)
3.3 Global Nodoame Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nodoame as of 2019)
3.4 Global Nodoame Average Price by Company (2015-2020)
3.5 Manufacturers Nodoame Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Nodoame Players (Opinion Leaders)
4 Global Nodoame Market Size by Type
4.1 Global Nodoame Historic Market Review by Type (2015-2020)
4.1.1 Global Nodoame Sales Market Share by Type (2015-2020)
4.1.2 Global Nodoame Revenue Market Share by Type (2015-2020)
4.1.3 Global Nodoame Price by Type (2014-2020)
4.2 Global Nodoame Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Nodoame Sales Forecast by Type (2021-2026)
4.2.2 Global Nodoame Revenue Forecast by Type (2021-2026)
4.2.3 Global Nodoame Price Forecast by Type (2021-2026)
5 Global Nodoame Market Size by Application
5.1 Global Nodoame Historic Market Review by Application (2015-2020)
5.1.1 Global Nodoame Sales Market Share by Application (2015-2020)
5.1.2 Global Nodoame Revenue Market Share by Application (2015-2020)
5.1.3 Global Nodoame Price by Application (2015-2020)
5.2 Global Nodoame Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Nodoame Sales Forecast by Application (2021-2026)
5.2.2 Global Nodoame Revenue Forecast by Application (2021-2026)
5.2.3 Global Nodoame Price Forecast by Application (2021-2026)

3 North America Nodoame Market Facts & Figures
3.2 North America Nodoame Sales Market Share by Company (2015-2020)
3.3 North America Nodoame Sales Market Share by Type (2015-2020)
3.4 North America Nodoame Sales Market Share by Application (2015-2020)

4 Europe Nodoame Market Facts & Figures
4.2 Europe Nodoame Sales Market Share by Company (2015-2020)
4.3 Europe Nodoame Sales Market Share by Type (2015-2020)
4.4 Europe Nodoame Sales Market Share by Application (2015-2020)

5 China Nodoame Market Facts & Figures
5.2 China Nodoame Sales Market Share by Company (2015-2020)
5.3 China Nodoame Sales Market Share by Type (2015-2020)
5.4 China Nodoame Sales Market Share by Application (2015-2020)

6 Japan Nodoame Market Facts & Figures
6.2 Japan Nodoame Sales Market Share by Company (2015-2020)
6.3 Japan Nodoame Sales Market Share by Type (2015-2020)
6.4 Japan Nodoame Sales Market Share by Application (2015-2020)

7 Southeast Asia Nodoame Market Facts & Figures
7.2 Southeast Asia Nodoame Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Nodoame Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Nodoame Sales Market Share by Application (2015-2020)

8 India Nodoame Market Facts & Figures
8.2 India Nodoame Sales Market Share by Company (2015-2020)
8.3 India Nodoame Sales Market Share by Type (2015-2020)
8.4 India Nodoame Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Nodoame Business
12.1 Comvita
12.1.1 Comvita Nodoame Corporation Information
12.1.2 Comvita Nodoame Business Overview and Total Revenue
12.1.3 Comvita Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Comvita Nodoame Products Offered
12.1.5 Comvita Recent Development
12.2 Vocalzone
12.2.1 Vocalzone Nodoame Corporation Information
12.2.2 Vocalzone Nodoame Business Overview and Total Revenue
12.2.3 Vocalzone Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Vocalzone Nodoame Products Offered
12.2.5 Vocalzone Recent Development
12.3 Good Health
12.3.1 Good Health Nodoame Corporation Information
12.3.2 Good Health Nodoame Business Overview and Total Revenue
12.3.3 Good Health Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Good Health Nodoame Products Offered
12.3.5 Good Health Recent Development
12.4 Kanro
12.4.1 Kanro Nodoame Corporation Information
12.4.2 Kanro Nodoame Business Overview and Total Revenue
12.4.3 Kanro Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Kanro Nodoame Products Offered
12.4.5 Kanro Recent Development
12.5 UHA Mikakuto Co.,Ltd
12.5.1 UHA Mikakuto Co.,Ltd Nodoame Corporation Information
12.5.2 UHA Mikakuto Co.,Ltd Nodoame Business Overview and Total Revenue
12.5.3 UHA Mikakuto Co.,Ltd Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.5.4 UHA Mikakuto Co.,Ltd Nodoame Products Offered
12.5.5 UHA Mikakuto Co.,Ltd Recent Development
12.6 RYUKAKUSAN Co.,Ltd.
12.6.1 RYUKAKUSAN Co.,Ltd. Nodoame Corporation Information
12.6.2 RYUKAKUSAN Co.,Ltd. Nodoame Business Overview and Total Revenue
12.6.3 RYUKAKUSAN Co.,Ltd. Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.6.4 RYUKAKUSAN Co.,Ltd. Nodoame Products Offered
12.6.5 RYUKAKUSAN Co.,Ltd. Recent Development
12.7 Zirkulin
12.7.1 Zirkulin Nodoame Corporation Information
12.7.2 Zirkulin Nodoame Business Overview and Total Revenue
12.7.3 Zirkulin Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Zirkulin Nodoame Products Offered
12.7.5 Zirkulin Recent Development
12.8 Ricola
12.8.1 Ricola Nodoame Corporation Information
12.8.2 Ricola Nodoame Business Overview and Total Revenue
12.8.3 Ricola Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ricola Nodoame Products Offered
12.8.5 Ricola Recent Development
12.9 Fisherman’s Friend
12.9.1 Fisherman’s Friend Nodoame Corporation Information
12.9.2 Fisherman’s Friend Nodoame Business Overview and Total Revenue
12.9.3 Fisherman’s Friend Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Fisherman’s Friend Nodoame Products Offered
12.9.5 Fisherman’s Friend Recent Development
12.10 Golden Throat Holdings Group Company Limited
12.10.1 Golden Throat Holdings Group Company Limited Nodoame Corporation Information
12.10.2 Golden Throat Holdings Group Company Limited Nodoame Business Overview and Total Revenue
12.10.3 Golden Throat Holdings Group Company Limited Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Golden Throat Holdings Group Company Limited Nodoame Products Offered
12.10.5 Golden Throat Holdings Group Company Limited Recent Development
12.11 Nin Jiom
12.11.1 Nin Jiom Nodoame Corporation Information
12.11.2 Nin Jiom Nodoame Business Overview and Total Revenue
12.11.3 Nin Jiom Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Nin Jiom Nodoame Products Offered
12.11.5 Nin Jiom Recent Development
12.12 Wong Lo Kat
12.12.1 Wong Lo Kat Nodoame Corporation Information
12.12.2 Wong Lo Kat Nodoame Business Overview and Total Revenue
12.12.3 Wong Lo Kat Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Wong Lo Kat Nodoame Products Offered
12.12.5 Wong Lo Kat Recent Development
12.13 Poon Goor Soe
12.13.1 Poon Goor Soe Nodoame Corporation Information
12.13.2 Poon Goor Soe Nodoame Business Overview and Total Revenue
12.13.3 Poon Goor Soe Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Poon Goor Soe Nodoame Products Offered
12.13.5 Poon Goor Soe Recent Development
12.14 Guilin Sanjin Pharmaceutical Company Limited
12.14.1 Guilin Sanjin Pharmaceutical Company Limited Nodoame Corporation Information
12.14.2 Guilin Sanjin Pharmaceutical Company Limited Nodoame Business Overview and Total Revenue
12.14.3 Guilin Sanjin Pharmaceutical Company Limited Nodoame Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Guilin Sanjin Pharmaceutical Company Limited Nodoame Products Offered
12.14.5 Guilin Sanjin Pharmaceutical Company Limited Recent Development

13 Nodoame Manufacturing Cost Analysis
13.1 Nodoame Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nodoame
13.4 Nodoame Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nodoame Distributors List
14.3 Nodoame Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Nodoame Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Nodoame Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Nodoame Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Nodoame Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Nodoame Players to Combat Covid-19 Impact
Table 8. Global Market Nodoame Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Nodoame Sales (K Units) by Region (2015-2020)
Table 10. Global Nodoame Sales Market Share by Region (2015-2020)
Table 11. Global Nodoame Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Nodoame Revenue Share by Region (2015-2020)
Table 13. Global Nodoame Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Nodoame Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Nodoame Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Nodoame Revenue Share Forecast by Region (2021-2026)
Table 17. Global Nodoame (K Units) of Key Companies (2015-2020)
Table 18. Global Nodoame Sales Share by Company (2015-2020)
Table 19. Global Nodoame Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Nodoame Revenue Share by Company (2015-2020)
Table 21. Global Nodoame by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nodoame as of 2019)
Table 22. Global Nodoame Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Nodoame Manufacturing Sites and Area Served
Table 24. Manufacturers Nodoame Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Nodoame Players
Table 27. Global Nodoame Sales (K Units) by Type (2015-2020)
Table 28. Global Nodoame Sales Share by Type (2015-2020)
Table 29. Global Nodoame Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Nodoame Price (K Units) by Type (2015-2020)
Table 31. Global Nodoame Sales Share by Type (2021-2026)
Table 32. Global Nodoame Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Nodoame Revenue Share by Type (2021-2026)
Table 34. Global Nodoame Price (K Units) by Type (2021-2026)
Table 35. Global Nodoame Sales (K Units) by Application (2015-2020)
Table 36. Global Nodoame Sales Share by Application (2015-2020)
Table 37. Global Nodoame Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Nodoame Price (K Units) by Application (2015-2020)
Table 39. Global Nodoame Sales (K Units) by Application (2021-2026)
Table 40. Global Nodoame Sales Share by Application (2021-2026)
Table 41. Global Nodoame Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Nodoame Revenue Share by Application (2021-2026)
Table 43. Global Nodoame Price (K Units) by Application (2021-2026)
Table 44. United States Nodoame Sales (K Units) by Company (2015-2020)
Table 45. United States Nodoame Sales Market Share by Company (2015-2020)
Table 46. United States Nodoame Sales (K Units) by Type (2015-2020)
Table 47. United States Nodoame Sales Market Share by Type (2015-2020)
Table 48. United States Nodoame Sales (K Units) by Application (2015-2020)
Table 49. United States Nodoame Sales Market Share by Application (2015-2020)
Table 50. Europe Nodoame Sales (K Units) by Company (2015-2020)
Table 51. Europe Nodoame Sales Market Share by Company (2015-2020)
Table 52. Europe Nodoame Sales (K Units) by Type (2015-2020)
Table 53. Europe Nodoame Sales Market Share by Type (2015-2020)
Table 54. Europe Nodoame Sales (K Units) by Application (2015-2020)
Table 55. Europe Nodoame Sales Market Share by Type (2015-2020)
Table 56. China Nodoame Sales (K Units) by Company (2015-2020)
Table 57. China Nodoame Sales Market Share by Company (2015-2020)
Table 58. China Nodoame Sales (K Units) by Type (2015-2020)
Table 59. China Nodoame Sales Market Share by Type (2015-2020)
Table 60. China Nodoame Sales (K Units) by Application (2015-2020)
Table 61. China Nodoame Sales Market Share by Application (2015-2020)
Table 62. Japan Nodoame Sales (K Units) by Company (2015-2020)
Table 63. Japan Nodoame Sales Market Share by Company (2015-2020)
Table 64. Japan Nodoame Sales (K Units) by Type (2015-2020)
Table 65. Japan Nodoame Sales Market Share by Type (2015-2020)
Table 66. Japan Nodoame Sales (K Units) by Application (2015-2020)
Table 67. Japan Nodoame Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Nodoame Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Nodoame Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Nodoame Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Nodoame Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Nodoame Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Nodoame Sales Market Share by Application (2015-2020)
Table 74. India Nodoame Sales (K Units) by Company (2015-2020)
Table 75. India Nodoame Sales Market Share by Company (2015-2020)
Table 76. India Nodoame Sales (K Units) by Type (2015-2020)
Table 77. India Nodoame Sales Market Share by Type (2015-2020)
Table 78. India Nodoame Sales (K Units) by Application (2015-2020)
Table 79. India Nodoame Sales Market Share by Application (2015-2020)
Table 80. Comvita Corporation Information
Table 81. Comvita Description and Business Overview
Table 82. Comvita Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Comvita Nodoame Product
Table 84. Comvita Recent Development
Table 85. Vocalzone Corporation Information
Table 86. Vocalzone Description and Business Overview
Table 87. Vocalzone Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Vocalzone Nodoame Product
Table 89. Vocalzone Recent Development
Table 90. Good Health Corporation Information
Table 91. Good Health Description and Business Overview
Table 92. Good Health Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Good Health Nodoame Product
Table 94. Good Health Recent Development
Table 95. Kanro Corporation Information
Table 96. Kanro Description and Business Overview
Table 97. Kanro Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Kanro Nodoame Product
Table 99. Kanro Recent Development
Table 100. UHA Mikakuto Co.,Ltd Corporation Information
Table 101. UHA Mikakuto Co.,Ltd Description and Business Overview
Table 102. UHA Mikakuto Co.,Ltd Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. UHA Mikakuto Co.,Ltd Nodoame Product
Table 104. UHA Mikakuto Co.,Ltd Recent Development
Table 105. RYUKAKUSAN Co.,Ltd. Corporation Information
Table 106. RYUKAKUSAN Co.,Ltd. Description and Business Overview
Table 107. RYUKAKUSAN Co.,Ltd. Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. RYUKAKUSAN Co.,Ltd. Nodoame Product
Table 109. RYUKAKUSAN Co.,Ltd. Recent Development
Table 110. Zirkulin Corporation Information
Table 111. Zirkulin Description and Business Overview
Table 112. Zirkulin Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Zirkulin Nodoame Product
Table 114. Zirkulin Recent Development
Table 115. Ricola Corporation Information
Table 116. Ricola Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Ricola Description and Business Overview
Table 118. Ricola Nodoame Product
Table 119. Ricola Recent Development
Table 120. Fisherman's Friend Corporation Information
Table 121. Fisherman's Friend Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Fisherman's Friend Description and Business Overview
Table 123. Fisherman's Friend Nodoame Product
Table 124. Fisherman's Friend Recent Development
Table 125. Golden Throat Holdings Group Company Limited Corporation Information
Table 126. Golden Throat Holdings Group Company Limited Description and Business Overview
Table 127. Golden Throat Holdings Group Company Limited Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Golden Throat Holdings Group Company Limited Nodoame Product
Table 129. Golden Throat Holdings Group Company Limited Recent Development
Table 130. Nin Jiom Corporation Information
Table 131. Nin Jiom Description and Business Overview
Table 132. Nin Jiom Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Nin Jiom Nodoame Product
Table 134. Nin Jiom Recent Development
Table 135. Wong Lo Kat Corporation Information
Table 136. Wong Lo Kat Description and Business Overview
Table 137. Wong Lo Kat Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Wong Lo Kat Nodoame Product
Table 139. Wong Lo Kat Recent Development
Table 140. Poon Goor Soe Corporation Information
Table 141. Poon Goor Soe Description and Business Overview
Table 142. Poon Goor Soe Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Poon Goor Soe Nodoame Product
Table 144. Poon Goor Soe Recent Development
Table . Guilin Sanjin Pharmaceutical Company Limited Corporation Information
Table . Guilin Sanjin Pharmaceutical Company Limited Description and Business Overview
Table . Guilin Sanjin Pharmaceutical Company Limited Nodoame Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Guilin Sanjin Pharmaceutical Company Limited Nodoame Product
Table . Guilin Sanjin Pharmaceutical Company Limited Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Nodoame Distributors List
Table 153. Nodoame Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Nodoame Product Picture
Figure 2. Global Nodoame Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nodoame Market Share by Application in 2020 & 2026
Figure 6. Supermarket Examples
Figure 7. Drugstore Examples
Figure 8. Global Nodoame Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Nodoame Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Nodoame Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Nodoame Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Nodoame Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Nodoame Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Nodoame Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Nodoame Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Nodoame Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Nodoame Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Nodoame Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Nodoame Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Nodoame Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Nodoame Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Nodoame Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Nodoame Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Nodoame Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Nodoame Players Market Share by Revenue in Nodoame 2015 & 2019
Figure 26. Nodoame Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Nodoame Revenue Share by Type (2015-2020)
Figure 28. Global Nodoame Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Nodoame Revenue Share by Application (2015-2020)
Figure 30. Global Nodoame Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Nodoame Sales Market Share by Type in 2019
Figure 32. United States Nodoame Sales Market Share by Type in 2019
Figure 33. Europe Nodoame Sales Market Share by Company in 2019
Figure 34. Europe Nodoame Sales Market Share by Type in 2019
Figure 35. Europe Nodoame Sales Market Share by Application in 2019
Figure 36. China Nodoame Sales Market Share by Company in 2019
Figure 37. China Nodoame Sales Market Share by Type in 2019
Figure 38. China Nodoame Sales Market Share by Application in 2019
Figure 39. Japan Nodoame Sales Market Share by Company in 2019
Figure 40. Japan Nodoame Sales Market Share by Type in 2019
Figure 41. Japan Nodoame Sales Market Share by Application in 2019
Figure 42. Southeast Asia Nodoame Sales Market Share by Company in 2019
Figure 43. Southeast Asia Nodoame Sales Market Share by Type in 2019
Figure 44. Southeast Asia Nodoame Sales Market Share by Application in 2019
Figure 45. India Nodoame Sales Market Share by Company in 2019
Figure 46. India Nodoame Sales Market Share by Type in 2019
Figure 47. India Nodoame Sales Market Share by Application in 2019
Figure 48. Comvita Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Vocalzone Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Good Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Kanro Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. UHA Mikakuto Co.,Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. RYUKAKUSAN Co.,Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Zirkulin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Ricola Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Fisherman's Friend Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Golden Throat Holdings Group Company Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Nin Jiom Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Wong Lo Kat Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Poon Goor Soe Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Guilin Sanjin Pharmaceutical Company Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Nodoame
Figure 64. Manufacturing Process Analysis of Nodoame
Figure 65. Nodoame Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed